|
|
||||||||


1 Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, UK
2 National Health Service Blood and Transplant, Cambridge Blood Centre, Cambridge, UK
3 Department of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Kumasi, Ghana
4 Transfusion Medicine Unit, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana
Correspondence
Jean-Pierre Allain
jpa1000{at}cam.ac.uk
Occult hepatitis B virus (HBV) infection (OBI), defined as the presence of HBV DNA without detectable HBV surface antigen (HBsAg), is frequent in west Africa, where genotype E is prevalent. The prevalence of OBI in 804 blood donors and 1368 pregnant women was 1.7 and 1.5 %, respectively. Nine of 32 OBI carriers were evaluated with HBV serology, viral load and complete HBV genome sequence of two to five clones. All samples except one were anti-HBV core antigen-positive and three contained antibodies against HBsAg (anti-HBs). All strains were of genotype E and formed quasispecies with 0.20–1.28 % intra-sample sequence variation. Few uncommon mutations (absent in 23 genotype E reference sequences) were found across the entire genome. Two mutations in the core region encoded truncated or abnormal capsid protein, potentially affecting viral production, but were probably rescued by non-mutated variants, as found in one clone. No evidence of escape mutants was found in anti-HBs-carrying samples, as the a region was consistently wild type. OBI carriers constitute approximately 10 % of all HBV DNA-viraemic adult Ghanaians. OBI carriers appear as a disparate group, with a very low viral load in common, but multiple origins reflecting decades of natural evolution in an area essentially devoid of human intervention.
Present address: Institute of Virology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, PR China.
Present address: Functional Genomics of Drug Resistance, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Cambridge, UK.
The GenBank/EMBL/DDBJ accession numbers for the nucleotide sequences analysed in this study are EU239217–EU239226.
A supplementary table showing primers used for sequencing full-length HBV amplicons is available with the online version of this paper.
This article has been cited by other articles:
![]() |
P. Garmiri, A. Loua, N. Haba, D. Candotti, and J.-P. Allain Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa J. Gen. Virol., October 1, 2009; 90(10): 2442 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. M. Meldal, N. M. Moula, I. H. A. Barnes, K. Boukef, and J.-P. Allain A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors J. Gen. Virol., July 1, 2009; 90(7): 1622 - 1628. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |